European journal of clinical investigation
-
Eur. J. Clin. Invest. · Aug 2021
Clustering of blood cell count abnormalities and future risk of death.
The identification of novel predictors of poor outcome may help stratify cardiovascular risk. Aim was to evaluate the individual contribution of blood cell count parameters, as well as their clustering, on the risk of death and cardiovascular events over the long term in the population-based Malmö Diet and Cancer Study cohort. ⋯ The easily assessable clustering of anaemia, leukocytosis and thrombocytosis heralds higher incidence of death and adverse cardiovascular events.
-
Eur. J. Clin. Invest. · Aug 2021
Impact of COVID-19 lockdown on routine oncology versus emergency care at a high volume cancer centre.
We investigated the influence of population-wide COVID-19 lockdown measures implemented on 16, March 2020 on routine and emergency care of cancer outpatients at a tertiary care cancer centre in Vienna, Austria. ⋯ We demonstrate the feasibility of maintaining antineoplastic therapy administration during the COVID-19 pandemic. However, our data underline the need for adapted management strategies for emergency presentations of cancer patients.
-
Eur. J. Clin. Invest. · Aug 2021
ReviewImmunopathophysiology and clinical impact of uveitis in inflammatory rheumatic diseases: an update.
Uveitis is one of the most frequent ophthalmologic manifestations in rheumatology. Uveal inflammation can underlie a systemic inflammatory rheumatic disease (SIRD) in approximately 30% of cases with a significant burden on the quality of life since it represents a cause of blindness in up to 20% of cases in Western countries. ⋯ Awareness among rheumatologists of a potential severe ocular involvement generates new insights into targeted therapeutic approaches and personalized treatments for each patient.